GLICLAZIDE SANDOZ MR gliclazide 60 mg modified release tablet blister pack

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

gliclazide, Quantity: 60 mg

Mevcut itibaren:

Sandoz Pty Ltd

Farmasötik formu:

Tablet, modified release

Kompozisyon:

Excipient Ingredients: magnesium stearate; lactose monohydrate; hypromellose

Uygulama yolu:

Oral

Paketteki üniteler:

60 tablets, 20 tablets

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Ürün özeti:

Visual Identification: White to off-white, biconvex oval shaped tablet with a deep break line on both sides. One side engraved with G and 60 on either side of break line.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

2022-06-17